| 000 | 01551 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513204931.0 | ||
| 264 | 0 | _c20000411 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/s0145-2126(99)00148-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosen, P J | |
| 245 | 0 | 0 |
_aA phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bLeukemia research _cMar 2000 |
||
| 300 |
_a183-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRankin, C | |
| 700 | 1 | _aHead, D R | |
| 700 | 1 | _aBoldt, D H | |
| 700 | 1 | _aLuthardt, F W | |
| 700 | 1 | _aNorwood, T | |
| 700 | 1 | _aPugh, R P | |
| 700 | 1 | _aKaranes, C | |
| 700 | 1 | _aAppelbaum, F R | |
| 773 | 0 |
_tLeukemia research _gvol. 24 _gno. 3 _gp. 183-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0145-2126(99)00148-4 _zAvailable from publisher's website |
| 999 |
_c10692481 _d10692481 |
||